Modifiable Factors Associated with Allopurinol Adherence and Outcomes Among Patients with Gout in An Integrated Healthcare System.

CONCLUSION: Among patients with gout initiating allopurinol in our study, 68% did not reach the SUA goal and 57% of patients were nonadherent. Modifiable factors, including allopurinol dose escalation, treatment adherence, rheumatology referral, and concomitant medication use, could be important factors to consider in efforts aimed at optimizing gout treatment outcomes. PMID: 25512479 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25512479?dopt=Abstract

Source: J Rheumatol - December 15, 2014 Category: Rheumatology Authors: Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR Tags: J Rheumatol Source Type: research

More News: Allopurinol | Gout | Rheumatology | Study